Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

Assertio Therapeutics Q4 Earnings Preview

Mar. 08, 2022 11:32 AM ETAssertio Holdings, Inc. (ASRT)By: Urvi Shah, SA News Editor
  • Assertio Therapeutics (NASDAQ:ASRT) is scheduled to announce Q4 earnings results on Wednesday, March 9th, before market open.
  • The consensus EPS Estimate is $0.12 (+160.0% Y/Y) and the consensus Revenue Estimate is $30.77M (+2.0% Y/Y).
  • Over the last 1 year, ASRT

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.